Melatonin and retinal cell damage: molecular and biological functions

Area of Science:

• Ophthalmology
• Neuroscience
• Endocrinology

Background:

• Melatonin is an indoleamine hormone crucial for physiological functions, primarily produced by the pineal gland.
• The eye, specifically photoreceptors, also produces melatonin with its own circadian rhythm, suggesting localized ocular functions.
• Existing research indicates melatonin's beneficial effects on eye-related disorders, particularly those affecting retinal cells.

Purpose of the Study:

• To explore the protective mechanisms of melatonin in retinal cells against damage and ischemia.
• To understand how melatonin modulates oxidative stress, inflammation, and cell death pathways in the retina.
• To evaluate the therapeutic potential of melatonin for treating retinal disorders.

Main Methods:

• Review of in vitro and in vivo studies on melatonin's effects on retinal cells.
• Analysis of melatonin's role in regulating oxidative stress response and antioxidant gene expression.
• Investigation of melatonin's modulation of inflammatory pathways (e.g., NF-кB) and programmed cell death (apoptosis, autophagy).

Main Results:

• Melatonin effectively mitigates retinal cell damage by regulating oxidative stress pathways.
• It modulates antioxidant gene expression, enhancing cellular defense mechanisms.
• Melatonin influences inflammatory responses and programmed cell death, contributing to retinal protection.

Conclusions:

• Melatonin demonstrates significant potential for protecting retinal cells from damage and ischemia.
• Its multifaceted mechanisms, including antioxidant and anti-inflammatory actions, highlight its therapeutic value.
• Further understanding of these mechanisms can lead to novel treatments for retinal disorders.